Yanyan Li, MD

Zhuhai Trinomab Pharmaceutical Co., Ltd.
Beijing, Beijing, China

Disclosure information not submitted.

Presentation(s):

• 560 - Efficacy and Safety of Retavibart, a Long-acting Monoclonal Antibody, for the Prevention of Respiratory Syncytial Virus-Induced Lower Respiratory Tract Infection: A Phase 2b Trial in Infants Entering Their First Epidemic Season

  Wednesday, October 22, 2025
  10:30 AM - 10:42 AM US ET